Achieve Life Sciences
(NASDAQ) ACHV
Achieve Life Sciences Financials at a Glance
Market Cap
$627.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$51.99M
EPS (TTM)
-$1.12
P/E Ratio
-5.48
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$6.12
Volume
2,050,664.872
Open
$6.37
Price
$6.12
Volume
2,050,664.872
Open
$6.37
Previous Close
$6.11
Daily Range
$5.81 - $6.40
52-Week Range
$2.37 - $7.11
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$6.12
Volume
2,050,664.872
Open
$6.37
Previous Close
$6.11
Daily Range
$5.81 - $6.40
52-Week Range
$2.37 - $7.11
Estimated Earnings Date
Aug 6, 2026
ACHV News
ACHV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Achieve Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
28
CEO
Richard Alistair Balfour Stewart
Website
www.achievelifesciences.comHeadquarters
Vancouver, BC V6E 4H1, CA
ACHV Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-193.49%
Return on Capital
-150.47%
Return on Assets
-157.04%
Earnings Yield
-18.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$627.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
102.66M
Volume
2.05M
Avg. Volume
2.06M
Financials (TTM)
Gross Profit
-$111.00K
Operating Income
-$52.45M
EBITDA
-$50.86M
Operating Cash Flow
-$45.31M
Capital Expenditure
-$3.00K
Free Cash Flow
-$45.31M
Cash & ST Invst.
$29.27M
Total Debt
$14.95M
Achieve Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$57.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$627.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$25.09M
N/A
Employees
25
N/A
Net Income
-$10.17M
+20.7%
EBITDA
-$9.84M
+21.8%
Quarterly Fundamentals
Total Cash
$29.27M
+25.9%
Total Debt
$14.95M
+50.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$9.32M
+7.0%
Short Term Debt
$5.63M
+350.0%
Return on Assets
-1.57%
N/A
Return on Invested Capital
-2.47%
N/A
Free Cash Flow
-$6.93M
+37.5%
Operating Cash Flow
-$6.93M
+37.5%